Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD

Summary

The purpose of this study is the evaluate the safety and tolerability of repeat dosing of the combination of inhaled GSK233705 and GW642444 administered once-daily in subjects with COPD.

Timeline

Start

2008-11-13

Primary completion

2009-02-12

Completion

2009-02-12

Publications

• Background GSK has submitted manuscripts of these study results to peer-reviewed scientific journals which were not accepted for publication. GSK is providing the attached study results summary with a conclusion.

Drugs

Indications